Licata Stephanie C, Schmidt Heath D, Pierce R Christopher
Department of Pharmacology, Laboratory of Neuropsychopharmacology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
Eur J Neurosci. 2004 Jan;19(2):405-14. doi: 10.1111/j.0953-816x.2003.03110.x.
In the present experiments we administered an alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonist (CNQX), N-methyl-D-aspartate (NMDA) receptor antagonist (AP-5), or l-type calcium channel blocker (diltiazem) directly into the ventral tegmental area (VTA) before each of four daily systemic cocaine injections in order to assess their influence on the initiation phase of behavioural sensitization. Results indicated that pretreatment with CNQX or AP-5 impaired the initiation of cocaine-induced behavioural sensitization. Intra-VTA administration of diltiazem significantly increased the behavioural activation induced by an acute cocaine injection, but impaired the development of cocaine-induced behavioural sensitization. Because AMPA and NMDA receptors, as well as l-type calcium channels are calcium permeable, we also investigated the role of the calcium-activated second messenger calcium/calmodulin-dependent protein kinase II (CaM-KII). Similar to the results obtained with diltiazem, administration of the CaM-KII inhibitor KN-93 into the VTA enhanced the acute behavioural response to cocaine but prevented the augmentation of cocaine-induced behavioural hyperactivity following repeated injections. Consistent with this finding, the behavioural hyperactivity produced by cocaine was markedly enhanced among homozygous alpha-CaM-KII knockout mice but the initiation of behavioural sensitization to cocaine was attenuated relative to wild-type mice. Separate experiments performed in rats demonstrated an increase in total protein levels of CaM-KII in the VTA 24 h after the last of seven daily injections of cocaine. Taken together, these results indicate that blocking l-type calcium channels or impairing CaM-KII activity in the VTA augments the acute behavioural hyperactivity induced by cocaine. The present findings also suggest that increased calcium influx through AMPA receptors, NMDA receptors and l-type calcium channels on dopaminergic neurons in the VTA contributes significantly to the initiation of behavioural sensitization by amplifying calcium signalling through CaM-KII.
在本实验中,我们在每日四次系统性注射可卡因之前,将α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体拮抗剂(CNQX)、N-甲基-D-天冬氨酸(NMDA)受体拮抗剂(AP-5)或L型钙通道阻滞剂(地尔硫卓)直接注射到腹侧被盖区(VTA),以评估它们对行为敏化起始阶段的影响。结果表明,用CNQX或AP-5预处理会损害可卡因诱导的行为敏化的起始。向VTA内注射地尔硫卓显著增加了急性可卡因注射诱导的行为激活,但损害了可卡因诱导的行为敏化的发展。由于AMPA和NMDA受体以及L型钙通道是钙可渗透的,我们还研究了钙激活的第二信使钙/钙调蛋白依赖性蛋白激酶II(CaM-KII)的作用。与用地尔硫卓获得的结果相似,将CaM-KII抑制剂KN-93注射到VTA中增强了对可卡因的急性行为反应,但阻止了重复注射后可卡因诱导的行为多动的增强。与此发现一致,在纯合α-CaM-KII基因敲除小鼠中,可卡因产生的行为多动明显增强,但相对于野生型小鼠,对可卡因的行为敏化起始减弱。在大鼠中进行的单独实验表明,在每日七次注射可卡因的最后一次注射后24小时,VTA中CaM-KII的总蛋白水平增加。综上所述,这些结果表明,阻断VTA中的L型钙通道或损害CaM-KII活性会增强可卡因诱导的急性行为多动。目前的研究结果还表明,通过VTA中多巴胺能神经元上的AMPA受体、NMDA受体和L型钙通道增加钙内流,通过CaM-KII放大钙信号,对行为敏化的起始有显著贡献。